Oncotarget

Research Papers:

High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers

Li Peng, Xiao-Qing Yuan, Zhao-Yang Liu, Wen-Ling Li, Chao-Yang Zhang, Ya-Qin Zhang, Xi Pan, Jun Chen, Yue-Hui Li and Guan-Cheng Li _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:1655-1667. https://doi.org/10.18632/oncotarget.13768

Metrics: PDF 2162 views  |   HTML 3212 views  |   ?  


Abstract

Li Peng1,2, Xiao-Qing Yuan3,4,*, Zhao-Yang Liu1,2, Wen-Ling Li1,2, Chao-Yang Zhang1,2, Ya-Qin Zhang1,2, Xi Pan5, Jun Chen1,2, Yue-Hui Li1,2, Guan-Cheng Li1,2,*

1Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha 410078, P.R. China

2Cancer Research Institute, Central South University, Changsha 410078, P.R. China

3Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China

4Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, P.R. China

5Department of Oncology, The third Xiangya Hospital, Central South University, Changsha 410013, P.R. China

*These authors have contributed equally to this work

Correspondence to:

Guan-Cheng Li, email: [email protected] or [email protected]

Keywords: H19, prognosis, female cancers, TCGA, meta-analysis

Received: June 30, 2016    Accepted: November 14, 2016    Published: December 01, 2016

ABSTRACT

Upregulation of lncRNA H19 expression is associated with an unfavorable prognosis in some cancers. However, the prognostic value of H19 in female-specific cancers has remained uncharacterized. In this study, the prognostic power of high H19 expression in female cancer patients from the TCGA datasets was analyzed using Kaplan-Meier survival curves and Cox’s proportional hazard modeling. In addition, in a meta-analysis of non-female cancer patients from TCGA datasets and 12 independent studies, hazard ratios (HRs) with 95% confidence interval (CI) for overall survival (OS) and disease-free survival (DFS)/relapse-free survival (RFS)/metastasis-free survival (MFS)/progression-free survival (PFS) were pooled to assess the prognostic value of high H19 expression. Kaplan-Meier analysis revealed that patients with uterine corpus cancer and higher H19 expression had a shorter OS (HR=2.710, p<0.05), while females with cervical cancer and increased H19 expression had a shorter RFS (HR=2.261, p<0.05). Multivariate Cox regression analysis showed that high H19 expression could independently predict a poorer prognosis in cervical cancer patients (HR=4.099, p<0.05). In the meta-analysis, patients with high H19 expression showed a poorer outcome in non-female cancer (p<0.05). These results suggest that high lncRNA H19 expression is predictive of an unfavorable prognosis in two female cancers (uterine corpus endometrioid cancer and cervical cancer) as well as in non-female cancer patients.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13768